Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Clinical trial NCT01443481 · COMPLETED

Trial details

NCT number: NCT01443481
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Hepatic Impairment

Start date: 2011-11-01
Primary completion: 2014-10-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.